Patent details
EP2893350 Title: RESISTANCE BIOMARKERS FOR HDAC INHIBITORS
Basic Information
- Publication number:
- EP2893350
- PCT Application Number:
- PCT/US/2013/058379
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP137671665
- PCT Publication Number:
- WO/2014/039744
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RESISTANCE BIOMARKERS FOR HDAC INHIBITORS
- French Title of Invention:
- BIOMARQUEURS DE RÉSISTANCE AUX INHIBITEURS DE HDAC
- German Title of Invention:
- RESISTENZBIOMARKER FÜR HDAC-HEMMER
- SPC Number:
Dates
- Filing date:
- 06/09/2013
- Grant date:
- 31/08/2016
- EP Publication Date:
- 31/08/2016
- PCT Publication Date:
- 13/03/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/07/2015
- EP B1 Publication Date:
- 31/08/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 06/09/2016
- Expiration date:
- 06/09/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/09/2013
- Name:
- Celgene Corporation
- Address:
- 86 Morris Avenue, Summit, NJ 07901, United States (US)
Inventor
- Name:
- TROWE Torsten, Bernhard
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201261698341
- Priority Date:
- 07/09/2012
- Priority Country:
- United States (US)
2
- Priority Number:
- 201261726464
- Priority Date:
- 14/11/2012
- Priority Country:
- United States (US)
3
- Priority Number:
- 201361784501
- Priority Date:
- 14/03/2013
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- G01N 33/574;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|